Condition
Spinal Muscular Atrophy Type 3 clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Spinal Muscular Atrophy Type 3 clinical trials that are recruiting, at sites in 8 countries (most in United States (3), China (1), Belgium (1)). By phase: Phase 1/2 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 8Countries
Newest Spinal Muscular Atrophy Type 3 clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Linking walking patterns to bone strength in ambulatory SMA | — | New York, New York | Recruiting | Feb 10, 2026 |
| Apitegromab for infants under 2 with spinal muscular atrophy | Phase 2 | Phoenix, Arizona and 22 other locations | Recruiting | Jul 2, 2025 |
| Identifying walking-related digital biomarkers in rare childhood neuromuscular disorders | — | Palo Alto, California and 2 other locations | Recruiting | Feb 21, 2025 |
| Gene therapy for treating spinal muscular atrophy type 3 | Phase 1/2 | Beijing, Beijing Municipality | Recruiting | May 20, 2024 |
All recruiting trials (4)
-
Linking walking patterns to bone strength in ambulatory SMA
This will try to see if wearable insole gait data can predict bone density and fracture risk in ambulatory people with spinal muscular atrophy who are on disease-modifying therapy.
-
Apitegromab for infants under 2 with spinal muscular atrophy
This trial will test whether adding apitegromab to approved SMA therapy helps infants under 2 with 5q SMA reach better motor milestones.
-
Identifying walking-related digital biomarkers in rare childhood neuromuscular disorders
This study is testing if special insoles with sensors can help track walking patterns in kids with spinal muscular atrophy or Duchenne muscular dystrophy to better understand their mobility.
-
Gene therapy for treating spinal muscular atrophy type 3
This study is testing a new gene therapy for people with spinal muscular atrophy type 3 to see if it is safe and helps improve their movement over time.
Related topics
Quick answers
How many Spinal Muscular Atrophy Type 3 clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in United States (3 trials), China (1 trial), Belgium (1 trial), France (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.